Israel’s Ministry of Health Approves ESE to Test Terpene Mix Against a Coronavirus Strain
Aug 1, 2021
Aug 1, 2021 |
14 min
eSense-Lab Ltd (ASX: ESE) has signed a research agreement with the Israeli Ministry of Health to commence a research project at the Central Virology lab in the Chaim Sheba Medical Centre — the largest hospital in Israel — to test its proprietary TRP-ENV™ compounds for a coronaviruses.
Recent contract wins validate eSense’s unique terpenes commercialisation model
Jul 15, 2020
Jul 15, 2020 |
5 min
eSense-Lab Limited (ASX:ESE) has achieved a number of key strategic milestones and contracts during the two recent quarters, leaving it well positioned to increase sales and revenue growth.
eSense appoints US distributor in $10M sales sourcing agreement
Jul 7, 2020
Jul 7, 2020 |
4 min
eSense-Lab Limited (ASX:ESE) is executing on its expansion into the US market — the world’s largest consumer base for terpene based products — entering an exclusive sales agency agreement with Blue Science Solutions LLC for the distribution of its future terpene based sanitiser products.
$2.6M Capped eSense-Lab Signs US$600k Revenue Deal
Jun 19, 2020
Jun 19, 2020 |
16 min
Backed by a new leadership team, ASX-listed biotech junior, eSense-Lab (ASX:ESE) is implementing a new business model that sees it enter joint venture (JV) agreements to quickly reach multiple revenue-generating markets.
eSense teams up with Wise Wine to target sanitiser market
Jun 18, 2020
Jun 18, 2020 |
3 min
eSense-Lab (ASX:ESE) has entered into a joint venture with Wise Wine Ltd, a family-owned wine company based in Western Australia
